Condition (MeSH)
Rubella Syndrome, Congenital
ClinicalTrials.gov lists 1 trial for Rubella Syndrome, Congenital or a narrower condition beneath it. Centers for Disease Control and Prevention has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
1 section measured, none recorded · 1 not measured yet · 1 not computed
1 of the 1 trial is tagged with Rubella Syndrome, Congenital itself; the rest are tagged with a narrower condition beneath it.
When did Rubella Syndrome, Congenital trials start? (1)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2017 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Rubella Syndrome, Congenital trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
How many Rubella Syndrome, Congenital trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Rubella Syndrome, Congenital trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Centers for Disease Control and Prevention | 1 |
Which serious adverse events do Rubella Syndrome, Congenital trials report? (4)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Hospitalization: Respiratory Infections | 9 | 1 |
| Hospitalization: other | 8 | 1 |
| Surgical procedure | 2 | 1 |
| Anaphylaxis | 0 | 1 |
Which publications cover Rubella Syndrome, Congenital? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review. | The Lancet. Global health | 2024 | Yes |
| Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review. | PloS one | 2016 | Yes |
| Associated systemic and ocular disorders in patients with congenital unilateral cataracts: the Infant Aphakia Treatment Study experience. | Eye (London, England) | 2016 | Yes |
| Impact of specific medical interventions on reducing the prevalence of mental retardation. | Archives of pediatrics & adolescent medicine | 2006 | No |
Prevalence (36)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Congenital rubella syndrome | Prevalence at birth | 1-9 / 1 000 000 | Spain | Not stated | Exact |
| Congenital rubella syndrome | Prevalence at birth | 1-9 / 1 000 000 | Netherlands | Not stated | Unspecified |
| Congenital rubella syndrome | Prevalence at birth | 1-9 / 100 000 | Romania | Not stated | Unspecified |
| Congenital rubella syndrome | Prevalence at birth | 1-9 / 1 000 000 | Italy | Not stated | Unspecified |
| Congenital rubella syndrome | Prevalence at birth | 1-9 / 1 000 000 | Germany | Not stated | Unspecified |
Showing 5 of 36 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Congenital rubella syndrome | 290 | Exact | Orphadata Science knowledge files, Product 1 |
| Congenital rubella syndrome | 290 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.